Thirty-six percent of Hispanic families in the U.S. with a common form of retinitis pigmentosa got the disease because they carry a mutation of the arrestin-1 gene, according to a new study from researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
Retinitis pigmentosa is a group of rare, genetic eye disorders in which the retina of the eye slowly degenerates. The disease causes night blindness and progressive loss of peripheral vision, sometimes leading to complete blindness. According to Stephen P. Daiger, Ph.D., senior author of the study, an estimated 300,000 people in the U.S. suffer from the disease, which gets passed down through families.
In the study published recently in Investigative Ophthalmology & Visual Science, UTHealth researchers found that in a U.S. cohort of 300 families with retinitis pigmentosa, 3 percent exhibited a mutation of the arrestin-1 gene. However, more than 36 percent of Hispanic families from the cohort exhibited the arestin-1 mutation and they all came from areas in the Southwestern U.S., such as Texas, Arizona and Southern California.
“When I started studying retinitis pigmentosa in 1985, we set out to find the ‘one’ gene that causes the disease. Thirty-three years later, we’ve found that more than 70 genes are linked to retinitis pigmentosa,” said Daiger, a professor in the Human Genetics Center and holder of the Thomas Stull Matney, Ph.D. Professorship in Environmental and Genetic Sciences at UTHealth School of Public Health.
Some of the genes that cause retinitis pigmentosa are recessive, which means two mutations are required, and some are dominant, which means you only need one mutation. Arrestin-1 piqued Daiger’s interest because that particular mutation is dominant while all previously found mutations in the gene are recessive. This unexpected finding shows that even a single mutation in the gene is sufficient to cause the disease.
Daiger and his team have identified the genetic cause of retinitis pigmentosa for 75 percent of families in their cohort. Possible treatments for some forms of retinitis pigmentosa are being tested but are still limited. However, the speed at which companies are developing gene therapies and small molecule therapies gives reason to hope, he said. Daiger and his collaborators have begun to connect some of the patients in the retinitis pigmentosa cohort to clinical trials that treat specific genes.
“I want our cohort families to know that even if there is not an immediate cure for their specific gene mutation, at this rate it won’t be long until a therapy becomes available,” said Daiger, who also holds the Mary Farish Johnston Distinguished Chair in Ophthalmology at McGovern Medical School at UTHealth.
UTHealth coauthors include Lori S. Sullivan, Ph.D.; Sara J. Browne, Ph.D.; Elizabeth L. Cadena; Richard S. Ruiz, M.D., and Hope Northrup, M.D. Additional co-authors are from Nationwide Children’s Hospital; Kellogg Eye Center at the University of Michigan; Retina Foundation of the Southwest; Casey Eye Institute at Oregon Health and Science University; Vanderbilt University and the Department of Molecular and Human Genetics at Baylor College of Medicine.
Support for the study, titled “A novel dominant mutation in SAG, the arrestin-1 gene, is a common cause of retinitis pigmentosa in Hispanic families in the Southwestern United States,” was provided by the William Stamps Farish Fund and the Hermann Eye Fund.
Additional support was provided by the National Institutes of Health (EY007142, EY009076, EY011500, EY010572 and K08-EY026650), a Wynn-Gund TRAP Award, the Foundation Fighting Blindness, the Max and Minnie Voelker Foundation and a grant to the Casey Eye Institute from Research to Prevent Blindness.
RT @BCMEthics: Alternative science: The importance of informed policymaking https://t.co/O3lLsZAsr3 via @bcmhouston
Here?s a tip: Indented cement shows unique properties. https://t.co/GuxKPV2NgV https://t.co/XBSiKhJ5IG
Congratulations to Drs. Jonathan Davies, James Orengo and Geoffrey Preidis, recipients of the 2017 Chao Physician-S? https://t.co/8OZYgv4laf
@BCMEthics' Cody Brannan says peer-reviewed data should be considered for science-based policymaking. https://t.co/nkLOkMfQ7h
Baylor College of MedicineBaylorCollegeOfMedicine
Baylor College of Medicine Center for Medical Ethics and Health Policy's Cody Brannan says peer-reviewed data and scientific consensus should be considered fo...
@RandyPro Congratulations, Randy! Best wishes to you.
CHI St Luke's Health@CHI_StLukes
RT @CHI_Updates: Even hours after a near-drowning incident, mild symptoms can cause serious complications - learn more with this info from?
Tips for enjoying a healthy #barbecue: https://t.co/p4NKLod53I @FocusedonHealth #endcancer https://t.co/iaP5EstrZP
RT @UTSDhouston: I scream! You scream! We all scream for ice cream! Dean Valenza's 9th Annual Scream Out ice? https://t.co/kzog82SPID
"This doctor, who I didn't know at the time, was going to change our lives." Read full story: https://t.co/3Kn1q4rap6 #texaschildrens
Magic Valley groups ride to honor Vietnam Veterans https://t.co/Bc1PCvQYfH via @emilydukeKMVT
Communities of cells communicate to coordinate their actions, but how do they coordinate with other communities?? https://t.co/TynLuAsTS6
#Trampolines are responsible for thousands of annual ER visits. Dr. Sasha Adams shared safety tips w/ @Fox26Houston: https://t.co/4sbo09Lc1j
After 3-year-old Ishaan fell into a pool and nearly drowned, he was fortunate to be in the care of Dr. Soham Roy: https://t.co/rCkS06zkUs
MD Anderson Cancer CenterMDAnderson
“I wasn’t going to give up. If there’s any chance, I’m going to take it,” Maria Newhouse recalls telling herself when she was diagnosed with breast cancer. Lea...